Gainers
- HeartCore Enterprises, Inc. (NASDAQ:HTCR) gained 111% to $2.03 after the company announced it entered into a license agreement with Transcosmos Digital Technology for its Apromore process mining tool.
- UserTesting, Inc. (NYSE:USER) shares climbed 92.8% to $7.44 after the company announced it will be acquired by Thoma Bravo and Sunstone Partners for $1.3 billion. The company also reported better-than-expected Q3 sales results.
- AgroFresh Solutions, Inc. (NASDAQ:AGFS) gained 69% to $2.65 after the company announced its board of directors agreed with Paine Schwartz Partners to pursue acquisition of the company for $3 per share.
- NuZee, Inc. (NASDAQ:NUZE) surged 63% to $0.54.
- Altra Industrial Motion Corp. (NASDAQ:AIMC) climbed 48.2% to $59.64 higher after the company announced it will be acquired by Regal Rexnord Corporation for $62 per share in cash.
- View, Inc. (NASDAQ:VIEW) surged 29% to $1.3608.
- Acorda Therapeutics, Inc. (NASDAQ:ACOR) gained 27% to $0.6195. Acorda Therapeutics said it sees FY22 sales of $116 million to $119.7 million.
- Impinj, Inc. (NASDAQ:PI) gained 26% to $112.79 after the company reported better-than-expected Q3 EPS and sales results. The company also issued Q4 sales guidance above analyst estimates.
- AgEagle Aerial Systems, Inc. (NYSE:UAVS) gained 24% to $0.5999. AgEagle's eBee X Series Drones are the first and only UAVs to be approved by the Federal Aviation Administration for operations over people in the United States.
- Oceaneering International, Inc. (NYSE:OII) shares gained 23.2% to $13.84 after the company reported better-than-expected Q3 EPS and sales results.
- Shopify Inc. (NYSE:SHOP) surged 18.3% to $34.38 after the company reported better-than-expected Q3 EPS results and issued guidance.
- North American Construction Group Ltd. (NYSE:NOA) surged 18% to $13.64 after the company reported better-than-expected Q3 EPS and sales results.
- The Greenbrier Companies, Inc. (NYSE:GBX) gained 16.8% to $32.25 after the company reported better-than-expected Q4 EPS and sales results.
- MSA Safety Incorporated (NYSE:MSA) rose 15.7% to $135.56 after the company reported better-than-expected Q3 results.
- Community Health Systems, Inc. (NYSE:CYH) gained 15% to $2.6450 following Q3 results.
- MarineMax, Inc. (NYSE:HZO) gained 15% to $33.96 after the company reported better-than-expected Q4 adjusted EPS and sales results.
- ServiceNow, Inc. (NYSE:NOW) rose 13.4% to $416.20 after the company reported better-than-expected Q3 EPS results.
- Aspen Aerogels, Inc. (NYSE:ASPN) climbed 12.2% to $12.30 following Q3 results.
- OneMain Holdings, Inc. (NYSE:OMF) rose 12% to $36.48 following upbeat quarterly earnings.
- Caterpillar Inc. (NYSE:CAT) gained 10.1% to $216.95 after the company reported better-than-expected Q3 EPS and sales results.
- Arista Networks, Inc. (NYSE:ANET) surged 9.2% to $118.94.
- The Aaron's Company, Inc. (NYSE:AAN) gained 7.8% to $10.66.
- Aegon N.V.. (NYSE:AEG) rose 7.3% to $4.6350. Aegon announced plans to combine its Dutch operations with a.s.r.
- 2U, Inc. (NASDAQ:TWOU) gained 7% to $6.14.
- Anheuser-Busch InBev SA/NV (NYSE:BUD) shares rose 6.5% to $50.31 following Q3 results.
- Teladoc Health, Inc. (NASDAQ:TDOC) shares rose 6% to $28.34 after the company reported better-than-expected Q3 EPS and sales results.
Losers
- Core Scientific, Inc. (NASDAQ:CORZ) dropped 71% to $0.2860 after the company said, given the uncertainty regarding its financial condition, substantial doubt exists about the company's ability to continue as a going concern for a reasonable period of time.
- Kalera Public Limited Company (NASDAQ:KAL) shares dipped 66% to $0.0713. Kalera priced its 68 million unit public offering at $0.13 per unit.
- Babcock & Wilcox Enterprises, Inc. (NYSE:BW) fell 26% to $5.91. Babcock & Wilcox said it sees FY23 adjusted EBITDA of $100 million to $120 million.
- Cardio Diagnostics Holdings Inc (NASDAQ:CDIO) fell 25.4% to $2.85. Cardio Diagnostics Holdings reported the completion of its business combination with Mana Capital Acquisition Corp.
- TransCode Therapeutics, Inc. (NASDAQ:RNAZ) dipped 24% to $0.8750. TransCode Therapeutics recently reported positive preclinical results with its lead candidate, TTX-MC138, in pancreatic adenocarcinoma.
- Sleep Number Corporation (NASDAQ:SNBR) dropped 23.3% to $28.10 following Q3 earnings.
- Meta Platforms, Inc. (NASDAQ:META) shares fell 22.6% to $100.47 after the company reported worse-than-expected Q3 EPS and issued Q4 revenue guidance with a midpoint below estimates. The company also guided FY23 expenses of $96 billion to $101 billion.
- Taysha Gene Therapies, Inc. (NASDAQ:TSHA) shares fell 21.3% to $1.6975 after the company priced a 14 million share public offering of common stock at $2 per share.
- Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) fell 21.4% to $8.65.
- Wolfspeed, Inc. (NASDAQ:WOLF) fell 20.4% to $84.75 after the company issued Q2 sales guidance below estimates.
- FormFactor, Inc. (NASDAQ:FORM) dropped 20.2% to $21.65 after the company reported worse-than-expected Q3 sales and issued Q4 guidance below estimates.
- Carriage Services, Inc. (NYSE:CSV) fell 19.7% to $25.75 after the company reported worse-than-expected Q3 EPS results.
- Horizon Bancorp, Inc. (NASDAQ:HBNC) dropped 18.9% to $16.04 after the company reported worse-than-expected Q3 EPS results.
- Barfresh Food Group, Inc. (NASDAQ:BRFH) fell 18% to $1.77.
- Align Technology, Inc. (NASDAQ:ALGN) fell 17.8% to $182.30 after the company reported worse-than-expected Q3 results.
- Credit Suisse Group AG (NYSE:CS) shares fell 17.8% to $3.94. Credit Suisse Group posted a Q3 loss of $1.58 per share.
- FTI Consulting, Inc. (NYSE:FCN) dropped 16.8% to $146.36 after the company lowered the high end of its 2022 EPS guidance.
- FedNat Holding Company (NASDAQ:FNHC) fell 16.6% to $0.3505 after the company announced voluntary Nasdaq delisting.
- Tricida, Inc. (NASDAQ:TCDA) fell 16.3% to $0.3908 after declining 15% on Wednesday.
- Healthcare Triangle, Inc. (NASDAQ:HCTI) dropped 15.4% to $0.2790.
- Amedisys, Inc. (NASDAQ:AMED) fell 14.4% to $90.19 after the company reported worse-than-expected Q3 results. Raymond James downgraded the stock from Outperform to Market Perform.
- Bionano Genomics, Inc.. (NASDAQ:BNGO) fell 13.4% to $2.20 after gaining over 8% on Wednesday.
- TriMas Corporation (NYSE:TRS) fell 12.3% to $25.07 following weak quarterly results.
- World Acceptance Corporation (NASDAQ:WRLD) dropped 11.2% to $91.72 following a Q2 loss.
- LendingClub Corporation (NYSE:LC) shares fell 8.5% to $10.67 after the company issued Q4 guidance below estimates.
- RLX Technology Inc. (NYSE:RLX) shares fell 7.8% to $1.5050 after jumping 43% on Wednesday.
- STMicroelectronics N.V. (NYSE:STM) fell 5.8% to $32.61 following Q3 results.
Loading...
Loading...
ALGNAlign Technology Inc
$142.00-0.39%
ANETArista Networks Inc
$117.750.27%
ASPNAspen Aerogels Inc
$3.10-%
BNGOBionano Genomics Inc
$1.61-0.62%
BRFHBarfresh Food Group Inc
$3.213.39%
BUDAnheuser-Busch InBev SA/NV
$62.30-0.27%
BWBabcock & Wilcox Enterprises Inc
$5.77-0.52%
CATCaterpillar Inc
$551.000.10%
CDIOCardio Diagnostics Holdings Inc
$2.55-1.19%
CORZCore Scientific Inc
$14.901.15%
CSVCarriage Services Inc
$42.322.77%
CYHCommunity Health Systems Inc
$3.126.12%
FCNFTI Consulting Inc
$164.031.24%
FORMFormFactor Inc
$49.42-%
GBXGreenbrier Companies Inc
$43.453.04%
HBNCHorizon Bancorp (IN)
$16.38-%
HCTIHealthcare Triangle Inc
$1.88-1.56%
HTCRHeartCore Enterprises Inc
$0.4500-1.19%
HZOMarineMax Inc
$23.278.59%
LCLendingClub Corp
$16.303.76%
METAMeta Platforms Inc
$596.750.42%
MSAMSA Safety Inc
$155.851.90%
NOANorth American Construction Group Ltd
$13.570.44%
NOWServiceNow Inc
$814.670.15%
OIIOceaneering International Inc
$24.153.29%
OMFOneMain Holdings Inc
$59.79-%
PIImpinj Inc
$153.57-%
RLXRLX Technology Inc
$2.45-%
RNAZTransCode Therapeutics Inc
$9.267.18%
SHOPShopify Inc
$147.820.01%
SNBRSleep Number Corp
$3.87-%
STMSTMicroelectronics NV
$21.990.09%
TDOCTeladoc Health Inc
$7.051.29%
TRSTriMas Corp
$32.12-%
TSHATaysha Gene Therapies Inc
$4.18-0.24%
UAVSAgEagle Aerial Systems Inc
$1.18-%
WOLFWolfspeed Inc
$17.16-0.11%
WRLDWorld Acceptance Corp
$140.89-%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
